How to Choose a Probiotic by CFU Count

What Is CFU?

CFU (Colony Forming Unit) is the unit of measurement that indicates the number of live and active microorganisms in a probiotic preparation. 1 CFU = 1 living bacterial cell capable of dividing and forming a colony.

Probiotic labels typically show counts such as:

• 1 billion CFU (1 × 10⁹) — low dose, suitable for general dietary use
• 10 billion CFU (1 × 10¹⁰) — standard for healthy adults
• 50 billion CFU (5 × 10¹⁰) — high dose, appropriate during antibiotics
• 450 billion CFU (4.5 × 10¹¹) — clinical dose, hospital context

CFU Count vs. Strain Identity — Which Matters More?

This is one of the most common mistakes made when buying probiotics: more CFU does not automatically mean a better product. Strain identity is more important.

Strain identity has three parts:

1. Genus — Lactobacillus
2. Species — rhamnosus
3. Strain — GG (clinically tested sub-strain)

For example: Lactobacillus rhamnosus GG has 300+ clinical trials, with proven efficacy for diarrhoea at just 1 billion CFU. A product with the same species but a different strain containing 50 billion CFU may not deliver the same result.

The core rule: Choose a product with a clinically tested strain at any CFU level rather than a high-CFU product with unknown strains.

What CFU Count Is Right for Me?

What to Look For Beyond CFU Count?

1. CFU Guarantee — At Manufacture vs. Expiry

Many manufacturers state CFU count at time of manufacture. However, bacteria die during storage. Look for products that guarantee CFU through expiry date — this means the stated count is still valid when you use the product.

SELF Probiotic Lactospore 60 caps uses spore-forming bacteria which are exceptionally stable and survive well even at room temperature.

2. Strain Designation

The label should show the complete strain identity. If only "Lactobacillus acidophilus" is listed with no strain code, this is a red flag — the manufacturer is likely using a cheap generic strain with no clinical data.

3. Storage Requirements

• Refrigerated products — require cold chain; CFU may decline if left at room temperature during shipping
• Room-temperature stable — lyophilised or spore-forming strains; more convenient and often equally effective

ICONFIT Boulardii 60caps is a good example of a room-temperature stable probiotic — Saccharomyces boulardii is a yeast, not a bacterium, and requires no refrigeration.

4. Capsule vs. Powder vs. Tablet

• Enteric-coated capsules — protect from stomach acid; suited to sensitive strains
• Matrix capsules — newer technology, protects without enteric coating
• Powder — fastest delivery; can be added to food or drinks
• Standard tablets — often cheapest, but most vulnerable to stomach acid

Where to Buy Quality Probiotics in Estonia?

At maxfit.ee's probiotic category you will find carefully selected probiotics with clearly stated strain identities.

FAQ

Is more CFU always better?

No. Very high doses can cause digestive discomfort, especially in the first week. For most healthy adults, 5–15 billion CFU per day is sufficient. Higher doses make sense only for specific situations such as post-antibiotic recovery.

Should probiotics be taken with food?

Yes, for most probiotics this is actually recommended — food neutralises some stomach acid, allowing more bacteria to survive. The exception is some clinically tested strains (e.g. LGG) which are effective even on an empty stomach.

How long should a probiotic course last?

For general gut health maintenance, continuous use is fine. For resolving a specific problem (e.g. post-antibiotic recovery), 4–8 weeks is often sufficient. It is advisable to continue even after the acute period to consolidate the effect.

References

1. Hill, C. et al. (2014). Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology & Hepatology, 11(8), 506–514.
2. Sanders, M. E. et al. (2019). Probiotics and prebiotics in intestinal health and disease: from biology to the clinic. Nature Reviews Gastroenterology & Hepatology, 16(10), 605–616.
3. Ouwehand, A. C. et al. (2002). Probiotics: an overview of beneficial effects. Antonie van Leeuwenhoek, 82(1–4), 279–289.
4. Venugopalan, V. et al. (2010). Regulatory oversight and safety of probiotic use. Emerging Infectious Diseases, 16(11), 1661–1665.